Alnylam Pharmaceuticals
ALNY
ALNY
431 hedge funds and large institutions have $18.6B invested in Alnylam Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 157 increasing their positions, 129 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.24% less ownership
Funds ownership: 93.9% → 93.66% (-0.24%)
11% less capital invested
Capital invested by funds: $21B → $18.6B (-$2.35B)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Holders
431
Holding in Top 10
7
Calls
$249M
Puts
$189M
Top Buyers
| 1 | +$112M | |
| 2 | +$89.3M | |
| 3 | +$81.4M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$63.7M |
| 5 |
RI
RTW Investments
New York
|
+$49.6M |
Top Sellers
| 1 | -$212M | |
| 2 | -$138M | |
| 3 | -$89.3M | |
| 4 |
Alkeon Capital Management
New York
|
-$73.7M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$40.4M |